Controversial Issues in Esophageal Cancer: Surgical Approach and Lymphadenectomy

  • Giovanni de Manzoni
  • Andrea Zanoni
  • Simone Giacopuzzi
Part of the Updates in Surgery book series (UPDATESSURG)


Surgery is still the mainstay in the curative treatment of resectable esophageal cancer. Nevertheless, controversies and debate exist about the optimal management in terms of surgical approach, extent of resection, location of the anastomosis, and optimal nodal dissection. Moreover, the correct role of multimodal treatments, whose use is constantly increasing, has still to be defined, as well as their impact on surgical approach and lymphadenectomy.


Esophageal Cancer Circumferential Resection Margin Resected Node Recurrent Nerve Anastomotic Recurrence 


  1. 1.
    Law S (2009) Surgery techniques: anastomotic technique and selection of location In: Blair A. Jobe CRT, Jr, John G. Hunter (ed) Esophageal cancer principles and practice. Demos Medical, New York, pp 525–534Google Scholar
  2. 2.
    Lam KY, Ma LT, Wong J (1996) Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 49:124–129PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Tsutsui S, Kuwano H, Watanabe M et al (1995) Resection margin for squamous cell carcinoma of the esophagus. Ann Surg 222:193–202PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Law S, Arcilla C, Chu KM, Wong J (1998) The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176:286–290PubMedCrossRefGoogle Scholar
  5. 5.
    Kuwano H, Masuda N, Kato H, Sugimachi K (2002) The subepithelial extension of esophageal carcinoma for determining the resection margin during esophagectomy: a serial histopathologic investigation. Surgery 131:14–21CrossRefGoogle Scholar
  6. 6.
    Casson AG, Darnton SJ, Subramanian S, Hiller L (2000) What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg 69:205–209PubMedCrossRefGoogle Scholar
  7. 7.
    Chao YK, Yeh CJ, Chang HK et al (2011) Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol 18:529–534PubMedCrossRefGoogle Scholar
  8. 8.
    Deeter M, Dorer R, Kuppusamy MK et al (2009) Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg 144:618–624PubMedCrossRefGoogle Scholar
  9. 9.
    Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA (2009) Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus 22:42–48PubMedCrossRefGoogle Scholar
  10. 10.
    Sujendran V, Wheeler J, Baron R et al (2008) Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg 95:191–194PubMedCrossRefGoogle Scholar
  11. 11.
    Saha AK, Sutton C, Rotimi O et al (2009) Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category. Ann Surg Oncol 16:1364–1370PubMedCrossRefGoogle Scholar
  12. 12.
    Griffiths EA, Brummell Z, Gorthi G et al (2006) The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol 32:413–419PubMedCrossRefGoogle Scholar
  13. 13.
    Pultrum BB, Honing J, Smit JK et al (2010) A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol 17:812–820PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Dexter SP, Sue-Ling H, McMahon MJ et al (2001) Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 48:667–670PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Khan OA, Fitzgerald JJ, Soomro I et al (2003) Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 88:1549–1552PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Shimada H, Okazumi S, Matsubara H et al (2006) Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after threefield lymph node dissection. World J Surg 30:1441–1449PubMedCrossRefGoogle Scholar
  17. 17.
    Peyre CG, Hagen JA, DeMeester SR et al (2008) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979–985PubMedCrossRefGoogle Scholar
  18. 18.
    Liu YP, Ma L, Wang SJ et al (2010) Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol 36:155–159PubMedCrossRefGoogle Scholar
  19. 19.
    Mariette C, Piessen G, Briez N, Triboulet JP (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371PubMedCrossRefGoogle Scholar
  20. 20.
    Kelty CJ, Kennedy CW, Falk GL (2010) Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol 5: 1467–1471PubMedCrossRefGoogle Scholar
  21. 21.
    Hsu WH, Hsu PK, Hsieh CC et al (2009) The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg 13:1913–1920PubMedCrossRefGoogle Scholar
  22. 22.
    Rizk NP, Ishwaran H, Rice TW et al (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251:46–50PubMedCrossRefGoogle Scholar
  23. 23.
    Altorki NK, Zhou XK, Stiles B et al M (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248:221–226PubMedCrossRefGoogle Scholar
  24. 24.
    Peyre CG, Hagen JA, DeMeester SR et al (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556PubMedCrossRefGoogle Scholar
  25. 25.
    Herrera LJ (2010) Extent of lymphadenectomy in esophageal cancer: how many lymph nodes is enough? Ann Surg Oncol 17:676–678PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Hu Y, Hu C, Zhang H et al (2010) How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol 17:784–790PubMedCrossRefGoogle Scholar
  27. 27.
    Groth SS, Virnig BA, Whitson BA et al (2010) Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg 139:612–620PubMedCrossRefGoogle Scholar
  28. 28.
    Tachimori Y, Nagai Y, Kanamori N et al (2011) Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus 24:33–38PubMedCrossRefGoogle Scholar
  29. 29.
    Smit JK, Pultrum BB, van Dullemen HM et al (2010) Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy. Am J Surg 200:446–453PubMedCrossRefGoogle Scholar
  30. 30.
    Johansson J, DeMeester TR, Hagen JA (2004) En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139:627–631PubMedCrossRefGoogle Scholar
  31. 31.
    Omloo JM, Lagarde SM, Hulscher JB (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992–1000PubMedCrossRefGoogle Scholar
  32. 32.
    Twine CP, Lewis WG, Morgan MA (2009) The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically. Histopathology 55:46–52PubMedCrossRefGoogle Scholar
  33. 33.
    Schwarz RE, Smith DD (2007) Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg 11:1384–1393PubMedCrossRefGoogle Scholar
  34. 34.
    Bollschweiler E, Besch S, Drebber U (2010) Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer. Ann Surg Oncol 17:3187–3194PubMedCrossRefGoogle Scholar
  35. 35.
    Jamieson GG, Lamb PJ, Thompson SK (2009) The role of lymphadenectomy in esophageal cancer. Ann Surg 250:206–209PubMedCrossRefGoogle Scholar
  36. 36.
    Qubain SW, Natsugoe S, Matsumoto M (2001) Micrometastases in the cervical lymph nodes in esophageal squamous cell carcinoma. Dis Esophagus 14:143–148PubMedCrossRefGoogle Scholar
  37. 37.
    Tachibana M, Kinugasa S, Hirahara N, Yoshimura H (2008) Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothorac Surg 34:427–431PubMedCrossRefGoogle Scholar
  38. 38.
    Kuge K, Murakami G, Mizobuchi S et al (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343–1349PubMedCrossRefGoogle Scholar
  39. 39.
    Chen J, Liu S, Pan J et al (2009) The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 36:480–486PubMedCrossRefGoogle Scholar
  40. 40.
    Motoyama S, Maruyama K, Sato Y et al (2009) Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and t2-4 thoracic squamous cell esophageal cancers. World J Surg 33:512–517PubMedCrossRefGoogle Scholar
  41. 41.
    Nakagawa S, Nishimaki T, Kosugi S et al (2003) Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagus. Dis Esophagus 16:4–8PubMedCrossRefGoogle Scholar
  42. 42.
    Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, diseasefree survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–972PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Tachibana M, Hirahara N, Kinugasa S, Yoshimura H (2008) Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol 15:104–116PubMedCrossRefGoogle Scholar
  44. 44.
    Mariette C, Piessen G, Balon JM et al (2004) Surgery alone in the curative treatment of localised oesophageal carcinoma. Eur J Surg Oncol 30:869–876PubMedCrossRefGoogle Scholar
  45. 45.
    Ancona E, Rampado S, Cassaro M et al (2008) Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 15:3278–3288PubMedCrossRefGoogle Scholar
  46. 46.
    Altorki N, Kent M, Ferrara C, Port J (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Prenzel KL, Bollschweiler E, Schroder W et al (2010) Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 90:1662–1667PubMedCrossRefGoogle Scholar
  48. 48.
    Fumagalli U, Akiyama H, DeMeester T (1996) Resective Surgery for Cancer of the Thoracic Esophagus: Results of a Consensus Conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Diseases of the Esophagus 9:30–38Google Scholar
  49. 49.
    Fujita H, Sueyoshi S, Tanaka T et al (2003) Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short-and long-term outcome among the four types of lymphadenectomy. World J Surg 27:571–579PubMedCrossRefGoogle Scholar
  50. 50.
    Altorki N (2005) En-bloc esophagectomy-the three-field dissection. In: Landreneau RJ, Martin RF (eds) Esophageal surgery, vol 85. Elsevier-Surgical Clinics of North America, pp 611–619Google Scholar
  51. 51.
    Tachibana M, Kinugasa S, Yoshimura H et al (2004) En-bloc esophagectomy for esophageal cancer. Am J Surg 188:254–260PubMedCrossRefGoogle Scholar
  52. 52.
    Fang W, Kato H, Tachimori Y et al (2003) Analysis of pulmonary complications after threefield lymph node dissection for esophageal cancer. Ann Thorac Surg 76:903–908PubMedCrossRefGoogle Scholar
  53. 53.
    Tachibana M, Kinugasa S, Yoshimura H (2005) Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 189:98–109PubMedCrossRefGoogle Scholar
  54. 54.
    Fang WT, Chen WH, Chen Y, Jiang Y (2007) Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma. Dis Esophagus 20:206–211PubMedCrossRefGoogle Scholar
  55. 55.
    Shim YM, Kim HK, Kim K (2010) Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 5:707–712PubMedCrossRefGoogle Scholar
  56. 56.
    Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239:483–490PubMedCentralPubMedCrossRefGoogle Scholar
  57. 57.
    Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51PubMedCrossRefGoogle Scholar
  58. 58.
    Law S, Wong J (2001) Two-field dissection is enough for esophageal cancer. Dis Esophagus 14:98–103PubMedCrossRefGoogle Scholar
  59. 59.
    Nozoe T, Kakeji Y, Baba H, Maehara Y (2005) Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 18:226–229PubMedCrossRefGoogle Scholar
  60. 60.
    Shimada H, Okazumi S, Shiratori T et al (2009) Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma. J Gastrointest Surg 13:619–625PubMedCrossRefGoogle Scholar
  61. 61.
    Griffith JF, Chan AC, Ahuja AT et al (2000) Neck ultrasound in staging squamous oesophageal carcinoma-a high yield technique. Clin Radiol 55:696–701PubMedCrossRefGoogle Scholar
  62. 62.
    van Vliet EP, van der Lugt A, Kuipers EJ (2007) Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with esophageal or gastric cardia cancer: a comparative study. J Surg Oncol 96:200–206PubMedCrossRefGoogle Scholar
  63. 63.
    Natsugoe S, Matsumoto M, Okumura H (2010) Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg 395:341–346PubMedCrossRefGoogle Scholar
  64. 64.
    Tachibana M, Kinugasa S, Yoshimura H et al (2003) Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 138:1383–1389PubMedCrossRefGoogle Scholar
  65. 65.
    Tabira Y, Yasunaga M, Tanaka M et al (2000) Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg 191:232–237PubMedCrossRefGoogle Scholar
  66. 66.
    Shiozaki H, Yano M, Tsujinaka T et al (2001) Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus 14:191–196PubMedCrossRefGoogle Scholar
  67. 67.
    Sato F, Shimada Y, Li Z et al (2002) Paratracheal lymph node metastasis is associated with cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 9:65–70PubMedCrossRefGoogle Scholar
  68. 68.
    Puli SR, Reddy JB, Bechtold ML et al (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479–1490PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Chang AC, Ji H, Birkmeyer NJ et al (2008) Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85:424–429PubMedCrossRefGoogle Scholar
  70. 70.
    Barreto JC, Posner MC (2010) Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol 16:3804–3810PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Connors RC, Reuben BC, Neumayer LA, Bull DA (2007) Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205:735–740PubMedCrossRefGoogle Scholar
  72. 72.
    Junginger T, Gockel I, Heckhoff S (2006) A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. Eur J Surg Oncol 32:749–755PubMedCrossRefGoogle Scholar
  73. 73.
    Rentz J, Bull D, Harpole D (2003) Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 125:1114–1120PubMedCrossRefGoogle Scholar
  74. 74.
    Wolff CS, Castillo SF, Larson DR (2008) Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy. Dis Esophagus 21:328–333PubMedCrossRefGoogle Scholar
  75. 75.
    Yekebas EF, Schurr PG, Kaifi JT et al (2006) Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases. J Surg Oncol 93:541–549PubMedCrossRefGoogle Scholar
  76. 76.
    Grotenhuis BA, van Heijl M, Zehetner J (2010) Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy? Ann Surg 252:823–830PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Giovanni de Manzoni
    • 1
  • Andrea Zanoni
  • Simone Giacopuzzi
  1. 1.Dept. of Surgery, Upper G.I. Surgery DivisionUniversity of VeronaVeronaItaly

Personalised recommendations